Barclays Maintains Underweight on Addus HomeCare, Lowers Price Target to $92

Benzinga Newsdesk www.benzinga.com Negative 94.5%

Neg 94.5% Neu 0% Pos 0%

Barclays analyst Andrew Mok maintains Addus HomeCare (NASDAQ:ADUS) with a Underweight and lowers the price target from $102 to $92.